Format

Send to

Choose Destination
J Biomed Mater Res A. 2019 Apr 22. doi: 10.1002/jbm.a.36702. [Epub ahead of print]

Corneal bioprinting utilizing collagen-based bioinks and primary human keratocytes.

Author information

1
Department of Dental Materials and Biomaterials Research, RWTH Aachen University Hospital, Aachen, Germany.
2
Department of Ophthalmology, RWTH Aachen University Hospital, Aachen, Germany.
3
Department of Chemical Engineering, McMaster University, Hamilton, Canada.
4
Medical Textiles and Biofabrication, Institute for Textile Technology (ITA), RWTH Aachen University, Aachen, Germany.
5
Interdisciplinary Center for Clinical Research IZKF, RWTH Aachen University Hospital, Aachen, Germany.
6
Aachen Center for Technology Transfer in Ophthalmology (ACTO), Aachen, Germany.
7
Tissue Engineering and Stem Cell Group, Singapore Eye Research Institute, Singapore, Singapore.
8
Singapore National Eye Centre, Singapore, Singapore.

Abstract

Corneal transplantation is the treatment of choice for patients with advanced corneal diseases. However, the outcome may be affected by graft rejection, high associated costs, surgical expertise, and most importantly the worldwide donor shortage. In recent years, bioprinting has emerged as an alternative method for fabricating tissue equivalents using autologous cells with architecture resembling the native tissue. In this study, we propose a freeform and cell-friendly drop-on-demand bioprinting strategy for creating corneal stromal 3D models as suitable implants. Corneal stromal keratocytes (CSK) were bioprinted in collagen-based bioinks as 3D biomimetic models and the geometrical outcome as well as the functionality of the bioprinted specimens were evaluated after in vitro culture. We showed that our bioprinting method is feasible to fabricate translucent corneal stromal equivalents with optical properties similar to native corneal stromal tissue, as proved by optical coherence tomography. Moreover, the bioprinted CSK were viable after the bioprinting process and maintained their native keratocyte phenotypes after 7 days in in vitro culture, as shown by immunocytochemistry. The proposed bioprinted human 3D corneal models can potentially be used clinically for patients with corneal stromal diseases.

KEYWORDS:

3D; bioprinting; collagen; corneal tissue engineering; hydrogel

PMID:
31012205
DOI:
10.1002/jbm.a.36702

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center